United Kingdom· GB-APID-28414111000001109
Mercaptamine 0.5% eye drops
A mercaptamine product containing mercaptamine, registered in United Kingdom by Special Order. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mercaptamine is registered in 13 of 19 countries.
Countries holding a registration under ATC S01XA21 (mercaptamine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Mercaptamine · ATC S01XA21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mercaptamine
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- S01XA21
- ATC class
- Mercaptamine
- Defined daily dose
- 0.4 ml, AT
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mercaptamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCYSTADROPSRECORDATI RARE DISEASES, INC.
- CzechiaCYSTADROPSRecordati Rare Diseases, Puteaux
- IrelandCystadrops 3.8 mg/mL eye drops solutionRecordati Rare Diseases
- PolandCystadropsRecordati Rare Diseases
- SwedenCystadrops 3,8 mg/ml Ögondroppar, lösningRecordati Rare Diseases
- FinlandCystadropsRecordati Rare Diseases
- BelgiumCystadrops 3.8 mg/mlRecordati Rare Diseases
- IcelandCYSTADROPSRecordati Rare Diseases*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cystadrops, Cystagon
- Liechtenstein · Cystadrops, Cystagon
- Norway · Cystadrops, Cystagon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01aa6b06-6ccb-4bc6-919f-f3fdcf814ace GET /v1/drugs/01aa6b06-6ccb-4bc6-919f-f3fdcf814ace?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "28414111000001109",
"desc": "Mercaptamine 0.5% eye drops (Special Order)",
"form": "Eye drops",
"vpid": "28422911000001108",
"source": "dmd",
"vtm_id": "776687008",
"strength": "5 mg",
"substance": "Mercaptamine",
"ingredient": "Mercaptamine hydrochloride",
"supplier_code": "8286711000001104"
}See everything about mercaptamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.